SEC Filing Record

Offering Amount

$6.6M

Strategy

VC

Exemption

06b

Date Filed

May 28, 2026

0002137627-26-000001

View on SEC EDGAR →

37A Read

The 'VII' designation indicates this is the seventh fund in a Bloom Opportunities series, marking a continuation vehicle rather than a new strategy — the two-GP structure with Seed Labs LLC and an individual suggests a partnership model where the entity handles operations while Kanaparti carries key-person risk exposure.

The absence of prior EDGAR filings from either GP indicates this manager operates below the $150M AUM threshold that triggers mandatory SEC registration, which means LPs cannot cross-reference historical fund documents, performance disclosures, or prior exemption claims through public records.

A $7M target in May 2026 positions this as a seed-stage continuation raise during a period when venture dry powder remains elevated but LP deployment into early-stage has been selective; filing timing suggests the prior vintage (VI) has distributed capital or reached a natural close point requiring fresh commitments.

Verify whether Seed Labs LLC is a management company, a co-investing entity, or a pass-through structure — if it functions as a blocker or parallel vehicle, confirm how economics and decision rights are split between it and Kanaparti, as this materially affects governance and fee allocation.

Full analysis (GP structure, exemption breakdown, and market context) is available to Pro members.

Unlock Pro · $29/month → Sign in

Principals

General Partners & Executives

Seed Labs LLC Shriank Kanaparti

BVP VII a Series of Bloom Opportunities Fund II LLC